Reta + CagReta + Cag
At a glance
A blend of retatrutide and cagrilintide, two peptides studied for appetite control and weight management.
Retatrutide + Cagrilintide combines two investigational peptide-based treatments that target different pathways involved in appetite, metabolism, and weight management. Retatrutide activates GLP-1, GIP, and glucagon receptors, helping to reduce appetite and food intake while supporting blood-sugar regulation and energy expenditure. Cagrilintide is a long-acting amylin analogue that promotes feelings of fullness and satiety, which may further reduce food intake. Together, these compounds are of research interest because their complementary mechanisms could potentially provide a broader approach to appetite control, metabolic health, and body-weight reduction. However, the specific retatrutide–cagrilintide combination has not yet been established as an approved treatment or proven in large clinical trials.
Order this product
Message us on WhatsApp at 07361 793324 or email rawpeptides@outlook.com with the product name and quantity. We'll confirm payment and delivery by reply.
Add a starter pack to any order for £10. Just mention it in your message.
Sold for research use only. Not for human consumption. Not for veterinary use.
Product details
Purity
99%+
Size
10mg
Form
Lyophilised Powder
Testing
On request
- Over 99% purity
- Sealed research vial
- Boxed with blister pack
- Store between 2°C and 8°C

